Paul Ashton - Net Worth and Insider Trading
Paul Ashton Net Worth
The estimated net worth of Paul Ashton is at least $508,305 dollars as of 2024-11-13. Paul Ashton is the President & CEO of EyePoint Pharmaceuticals Inc and owns about 45,752 shares of EyePoint Pharmaceuticals Inc (EYPT) stock worth over $508,305. Details can be seen in Paul Ashton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul Ashton has not made any transactions after 2015-12-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul Ashton
Paul Ashton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul Ashton owns 1 companies in total, including EyePoint Pharmaceuticals Inc (EYPT) .
Click here to see the complete history of Paul Ashton’s form 4 insider trades.
Insider Ownership Summary of Paul Ashton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EYPT | EyePoint Pharmaceuticals Inc | 2015-12-22 | director & President and CEO |
Paul Ashton Latest Holdings Summary
Paul Ashton currently owns a total of 1 stock. Paul Ashton owns 45,752 shares of EyePoint Pharmaceuticals Inc (EYPT) as of December 22, 2015, with a value of $508,305.
Latest Holdings of Paul Ashton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EYPT | EyePoint Pharmaceuticals Inc | 2015-12-22 | 45,752 | 11.11 | 508,305 |
Holding Weightings of Paul Ashton
Paul Ashton Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul Ashton has made a total of 0 transactions in EyePoint Pharmaceuticals Inc (EYPT) over the past 5 years. The most-recent trade in EyePoint Pharmaceuticals Inc is the sale of 12,000 shares on December 22, 2015, which brought Paul Ashton around $646,800.
Insider Trading History of Paul Ashton
- 1
Paul Ashton Trading Performance
Paul Ashton Ownership Network
Ownership Network List of Paul Ashton
Ownership Network Relation of Paul Ashton
Paul Ashton Owned Company Details
What does EyePoint Pharmaceuticals Inc do?
Who are the key executives at EyePoint Pharmaceuticals Inc?
Paul Ashton is the director & President and CEO of EyePoint Pharmaceuticals Inc. Other key executives at EyePoint Pharmaceuticals Inc include director & President and CEO Nancy Lurker , SVP & Chief Commercial Officer David Scott Jones , and Chief Medical Officer Dario A. Paggiarino .
EyePoint Pharmaceuticals Inc (EYPT) Insider Trades Summary
Over the past 18 months, Paul Ashton made no insider transaction in EyePoint Pharmaceuticals Inc (EYPT). Other recent insider transactions involving EyePoint Pharmaceuticals Inc (EYPT) include a net sale of 943,936 shares made by Ew Healthcare Partners, L.p. , a net sale of 121,307 shares made by Dario A. Paggiarino , and a net purchase of 4,794,057 shares made by Cormorant Asset Management, Lp .
In summary, during the past 3 months, insiders sold 0 shares of EyePoint Pharmaceuticals Inc (EYPT) in total and bought 23,240 shares, with a net purchase of 23,240 shares. During the past 18 months, 4,229,811 shares of EyePoint Pharmaceuticals Inc (EYPT) were sold and 4,817,297 shares were bought by its insiders, resulting in a net purchase of 587,486 shares.
EyePoint Pharmaceuticals Inc (EYPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
EyePoint Pharmaceuticals Inc Insider Transactions
Paul Ashton Mailing Address
Above is the net worth, insider trading, and ownership report for Paul Ashton. You might contact Paul Ashton via mailing address: C/o Psivida Limited, 400 Pleasant Street, Watertown Ma 02472.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
